Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AIDS With Tuberculosis”

150 trials

Showing 20 of 150 results

Testing effectiveness (Phase 2)Study completedNCT04930744
What this trial is testing

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)

Who this might be right for
TuberculosisPulmonary TuberculosisHIV Coinfection
University of Massachusetts, Worcester 112
Testing effectiveness (Phase 2)Study completedNCT02906007
What this trial is testing

Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIV

Who this might be right for
TuberculosisHIV
National Institute of Allergy and Infectious Diseases (NIAID) 54
Not applicableNot Yet RecruitingNCT06019052
What this trial is testing

Evaluating Next Generation LAM Assays and Molecular Diagnostics (POC and Near POC) for the Diagnosis of TB Among People With Presumptive TB: a Prospective Multicentre Diagnostic Accuracy Study

Who this might be right for
Tuberculosis
Foundation for Innovative New Diagnostics, Switzerland 1,890
Testing effectiveness (Phase 2)Ended earlyNCT01424501
What this trial is testing

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease

Who this might be right for
Tuberculosis
GlaxoSmithKline 142
Testing effectiveness (Phase 2)UnknownNCT00474435
What this trial is testing

Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis

Who this might be right for
TuberculosisHIV Infections
African Poverty Related Infection Oriented Research Initiative 30
Post-approval studies (Phase 4)Study completedNCT02057796
What this trial is testing

Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 1,050
Not applicableStudy completedNCT02729532
What this trial is testing

Effect of Xpert MTB/RIF on Patient Outcomes

Who this might be right for
Tuberculosis
University of North Carolina, Chapel Hill 776
Post-approval studies (Phase 4)Study completedNCT00023400
What this trial is testing

TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB

Who this might be right for
HIV InfectionsTuberculosis
Centers for Disease Control and Prevention 20
Testing effectiveness (Phase 2)Study completedNCT00640887
What this trial is testing

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa

Who this might be right for
HIV InfectionsTuberculosis
French National Agency for Research on AIDS and Viral Hepatitis 48
Large-scale testing (Phase 3)Study completedNCT01404312
What this trial is testing

Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)

Who this might be right for
TuberculosisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 3,000
Not applicableLooking for participantsNCT07117370
What this trial is testing

Assessing the Feasibility of Coach Mpilo for Men With TB and HIV

Who this might be right for
TuberculosisHIV
Arizona State University 240
Large-scale testing (Phase 3)UnknownNCT05575518
What this trial is testing

A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary Tuberculosis

Who this might be right for
TuberculosisHuman Immunodeficiency Virus
Stellah Mpagama 414
Not applicableStudy completedNCT00000796
What this trial is testing

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 525
Large-scale testing (Phase 3)Study completedNCT02178592
What this trial is testing

Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 113
Large-scale testing (Phase 3)WithdrawnNCT00414414
What this trial is testing

A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infection

Who this might be right for
TuberculosisHIV Infections
Ottawa Hospital Research Institute
Large-scale testing (Phase 3)Looking for participantsNCT06497465
What this trial is testing

Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment

Who this might be right for
TuberculosisHIV
Johns Hopkins University 150
Early research (Phase 1)Ended earlyNCT00743470
What this trial is testing

A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects

Who this might be right for
HIVTuberculosis
Abbott 15
Early research (Phase 1)Study completedNCT00480558
What this trial is testing

MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both

Who this might be right for
HIV InfectionsTB
University of Oxford 48
Large-scale testing (Phase 3)Study completedNCT00933790
What this trial is testing

Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis

Who this might be right for
HIV InfectionPulmonary TB
Tuberculosis Research Centre, India 331
Testing effectiveness (Phase 2)Study completedNCT04556981
What this trial is testing

Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine M72/AS01E in Participants With Well-controlled HIV

Who this might be right for
Human Immunodeficiency Virus
Gates Medical Research Institute 402
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation